Molina Healthcare, Inc. (MOH) — ESG & Values Scores

Environment story

Molina Healthcare has not disclosed material Scope 1, 2, or 3 emissions data, net-zero targets, or dedicated decarbonization initiatives in its 10-K filing. The company operates as a health insurance managed-care entity with limited direct operational carbon footprint; however, absent explicit climate commitments, renewable energy targets, or supply-chain emissions tracking, the environmental pillar reflects substantial disclosure gaps. No resource controversies (toxic waste, water, habitat) identified in provided documents. Starting score of 100 reduced by 15 for undisclosed Scope 3 emissions and target net-zero year, and another 15 for absence of verified decarbonization infrastructure investments.

Criticisms on file

No material criticisms on file for this pillar.

Disclosed initiatives

No disclosed initiatives on file for this pillar.

Social story

Molina Healthcare reports workforce and leadership diversity metrics are not explicitly disclosed in the 10-K. CEO-to-median-worker pay ratio is not disclosed. No documented union-suppression activities or major strikes within 24 months identified. The company operates a health plan serving 5.5 million Medicaid, Medicare, and Marketplace members; supply-chain risks center on pharmacy benefit manager (Caremark) litigation and pharmaceutical pricing practices rather than direct human-rights hazards. The Molina Healthcare Charitable Foundation (established 2020, $27M cumulative contributions as of Dec 31, 2025) funds grants addressing social determinants of health. Absence of explicit diversity targets and pay-equity disclosures results in a 15-point deduction; no union/strike penalties or supply-chain human-rights evidence identified.

Criticisms on file

No material criticisms on file for this pillar.

Disclosed initiatives

Molina Healthcare Charitable Foundation

Established in 2020; $27 million in cumulative contributions as of December 31, 2025. Funded over 900 grants to local community organizations in 29 states addressing social determinants of health, disaster relief, behavioral health, maternal child health.

Community health and social equity investment; direct funding to underserved populations.

Governance story

Molina Healthcare's governance structure is not detailed exhaustively in the 10-K excerpts provided. Board independence percentage is not disclosed. The company does not employ a dual-class share structure (single common stock class implied by equity discussions). Lobbying expenditures are not explicitly quantified in the document. Regulatory compliance and potential fines are referenced generically (False Claims Act risk, HIPAA breaches, fraud/abuse investigations) but no active material antitrust, consumer-safety, or financial-fraud proceedings are detailed. The company amended its Credit Facility covenant on February 4, 2026, temporarily reducing the minimum Interest Coverage Ratio, indicating recent covenant stress but no breach. Deductions: 15 points for non-disclosure of board independence; no deduction for dual-class (none exists); no specific lobbying figures (conservative no penalty); no active material regulatory fines disclosed (no penalty). Conservative scoring reflects governance opacity in provided filings.

Criticisms on file

HIPAA Breach History
Source: MOH 10-K: 'We have experienced HIPAA breaches in the past, including breaches affecting over 500 individuals.' Form 10-K, Item 1A Risk Factors, 'Our use and disclosure of personal information…'
Exposure to False Claims Act and Qui Tam Litigation
Source: MOH 10-K: 'Qui tam actions under federal and state law are brought by a private individual, known as a relator, on behalf of the government.' Form 10-K, Item 1A Risk Factors, 'We are subject to extensive fraud and abuse laws…'
Pharmacy Benefit Manager (Caremark) Litigation
Source: MOH 10-K: 'Our principal pharmacy benefit manager, or PBM, Caremark, is party to certain lawsuits and putative class actions regarding its drug pricing practices and its rebate arrangements with drug manufacturers. The ultimate outcome of these complaints may have an adverse impact on our pharmaceutical costs, or potentially could result in our becoming involved or impleaded into similar or related costly litigation.' Form 10-K, Item 1A Risk Factors, 'Increases in our pharmaceutical costs could have a material adverse effect…'

Disclosed initiatives

Cybersecurity Risk Management

Company maintains cybersecurity insurance and implements policies, employee training (phishing prevention), technical safeguards, and multi-vendor risk management. Exposure to ransomware, social engineering, and cloud-based threats acknowledged.

Operational resilience and data protection; insurance coverage mitigates some financial liability from breaches.
Compliance Programs and Fraud Detection

Company required to maintain compliance programs to detect and deter fraud, waste, and abuse under Medicaid/Medicare participation rules.

Regulatory alignment and reduced legal/financial exposure to false claims penalties.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Molina Healthcare, Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Molina Healthcare, Inc. in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)